Alkermes (ALKS) EV to EBITDA (2012 - 2026)
Alkermes' (ALKS) EV to EBITDA came in at 45.41 for Q2 2026, up 394.0% from 9.19 a year earlier and up 95.2% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) EV to EBITDA (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EV to EBITDA at Alkermes was 33.04; for FY2025, it was 14.39, up 65.2% from FY2024.
- In prior years, Alkermes' EV to EBITDA was 8.71 in FY2024 (+10.4%), 7.89 in FY2023 (-84.6%), 51.37 in FY2022 (+180.5%) and 18.31 in FY2021.
- The Q2 2026 figure stands as the highest quarterly EV to EBITDA since Q1 2023.
- On a year-over-year basis, EV to EBITDA has increased in each of the last three quarters, with growth averaging 85.4% over the last eight quarters.
- The strongest year-over-year quarter for EV to EBITDA in the past five years was Q2 2026, with growth of 394.0%; the weakest was Q3 2022, with a decline of 87.6%.
- According to Business Quant data, EV to EBITDA for the three prior quarters was 23.26 (Q1 2026), 14.39 (Q4 2025) and 9.88 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.41 |
| Mar 31, 2026 | 23.26 |
| Dec 31, 2025 | 14.39 |
| Sep 30, 2025 | 9.88 |
| Jun 30, 2025 | 9.19 |
| Mar 31, 2025 | 10.88 |
| Dec 31, 2024 | 8.71 |
| Sep 30, 2024 | 10.26 |
| Jun 30, 2024 | 8.95 |
| Mar 31, 2024 | 7.20 |
| Dec 31, 2023 | 7.89 |
| Sep 30, 2023 | 6.86 |
| Jun 30, 2023 | 10.89 |
| Mar 31, 2023 | 46.96 |
| Dec 31, 2022 | 51.37 |
| Sep 30, 2022 | 35.48 |
| Jun 30, 2022 | 33.73 |
| Mar 31, 2022 | 22.71 |
| Dec 31, 2021 | 18.31 |
| Sep 30, 2021 | 286.66 |
API Access
Alkermes EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();